Targeted Therapy and Local Control: The Dynamic Duo

Ann Surg Oncol. 2017 Oct;24(11):3110-3112. doi: 10.1245/s10434-017-6022-0. Epub 2017 Jul 26.

Authors

Anita Mamtani¹, Tari A King²

Affiliations

¹ Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
² Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. [email protected].

PMID: 28748442
DOI: 10.1245/s10434-017-6022-0

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents, Immunological / therapeutic use*
Breast Neoplasms / metabolism
Breast Neoplasms / therapy*
Chemotherapy, Adjuvant
Female
Humans
Mastectomy, Segmental
Molecular Targeted Therapy
Neoplasm Recurrence, Local / prevention & control*
Receptor, ErbB-2 / metabolism
Trastuzumab / therapeutic use*

Substances

Antineoplastic Agents, Immunological
ERBB2 protein, human
Receptor, ErbB-2
Trastuzumab